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ABSTRACT
Defects in SLX4, a scaffold for DNA repair nucleases, result in
Fanconi anemia (FA), due to the defective repair of inter-strand DNA
crosslinks (ICLs). Some FA patients have an SLX4 deletion
removing two tandem UBZ4-type ubiquitin-binding domains that
are implicated in protein recruitment to sites of DNA damage. Here,
we show that human SLX4 is recruited to sites of ICL induction but
that the UBZ-deleted form of SLX4 in cells from FA patients is not.
SLX4 recruitment does not require either the ubiquitylation of
FANCD2 or the E3 ligases RNF8, RAD18 and BRCA1. We show
that the first (UBZ-1) but not the second UBZ domain of SLX4 binds
to ubiquitin polymers, with a preference for K63-linked chains.
Furthermore, UBZ-1 is required for SLX4 recruitment to ICL sites
and for efficient ICL repair in murine fibroblasts. The SLX4 UBZ-2
domain does not bind to ubiquitin in vitro or contribute to ICL repair,
but it is required for the resolution of Holliday junctions in vivo.
These data shed light on SLX4 recruitment, and they point to the
existence of currently unidentified ubiquitylated ligands and E3
ligases that are crucial for ICL repair.
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INTRODUCTION
Human SLX4 is a scaffold that coordinates the structure-selective
nucleases XPF–ERCC1, MUS81–EME1 and SLX1 (Fekairi et al.,
2009; Mun˜oz et al., 2009; Svendsen et al., 2009), which together
can cleave branched DNA repair intermediates. SLX1 and
MUS81–EME1, for example, act together to resolve Holliday
junctions that escape dissolution by the BLM–TOP3–RMI1–
RMI2 (BTR) complex; these junctions are thought to arise during
repair of collapsed replication forks. The tethering of MUS81 and
SLX1 to the SLX4 scaffold coordinates the dual incisions, made
by the two nucleases, that are required for Holliday junction
resolution (Castor et al., 2013; Wyatt et al., 2013). SLX4,
together with associated nucleases, is important for the repair of
DNA inter-strand crosslinks (ICLs) and, consequently, bi-allelic
mutations in SLX4 (also known as FANCP) cause Fanconi
anemia (FA) (Kim et al., 2011; Stoepker et al., 2011), a rare
condition characterized by developmental defects, bone marrow
failure and cancer predisposition (Moldovan and D’Andrea,
2009). We previously described three German siblings with FA
(patients 457/1–3) caused by a small deletion in SLX4 that
removes all of the second and most of the first of two tandem
UBZ4-type ubiquitin-binding domains (Fig. 1A) (Stoepker et al.,
2011). Therefore, one or both of the UBZ domains are vital for
SLX4 function in ICL repair.
UBZ4-type domains have been implicated in recruiting
proteins such as FAN1 to sites of DNA damage (Hofmann,
2009). SLX4 recruitment to sub-nuclear foci in mitomycin-C-
treated DT-40 cells was reported to require both the single UBZ
domain in chicken SLX4 and mono-ubiquitylation of FANCD2
(Yamamoto et al., 2011). The latter is a central component of the
FA pathway that is mono-ubiquitylated by the FA core complex
at Lys561 in response to ICLs (Garcia-Higuera et al., 2001;
Taniguchi et al., 2002). Mono-ubiquitylated FANCD2 recruits the
FAN1 nuclease to sites of DNA damage through a UBZ4 domain
in human cells but it is not yet clear whether this also applies to
SLX4. Although the recruitment of proteins such as FANCD2 can
be visualized by the formation of sub-nuclear foci at the sites of
DNA damage, this visualization is difficult for SLX4 because it
forms foci (corresponding to telomeres) even in the absence of
DNA damage (Wilson et al., 2013).
It is not clear why mammalian SLX4 has two UBZ domains
whereas SLX4 homologs in some other eukaryotes have only one.
It is not known whether one or both of the UBZ domains in
human SLX4 are required for recruitment of the protein to sites of
DNA damage, for DNA repair and/or for Holliday junction
resolution. Furthermore, it is not yet clear whether defective
recruitment of SLX4 in FA cells expressing UBZ-deleted SLX4
explains the ICL repair defects in these cells. In this study, we
address these issues.
RESULTS AND DISCUSSION
SLX4 containing UBZ deletion fails to localize to sites of ICL
induction in FA cells
We tested the ability of human SLX4 to localize along a track of
ICLs induced by psoralen conjugates (Thazhathveetil et al.,
2007). Human U2OS cells stably expressing GFP–SLX4 were
exposed to trimethyl-psoralen (TMP) and micro-irradiated along
a track in cell nuclei using a 355-nm UV-A laser. As shown in
Fig. 1B, GFP–SLX4 (upper panels), but not GFP (middle panels),
formed a stripe along the laser track, which also contained the
phosphorylated histone variant c-H2AX; no stripe was formed
when cells had not been exposed to TMP (Fig. 1B, lower panels).
Indirect immunofluorescence analysis with antibodies raised in-
house (Wilson et al., 2013) revealed that endogenous SLX4 was
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also recruited to sites of psoralen–UVA laser (PUVA)-induced
DNA damage (Fig. 1C). Every cell that had a stripe of c-H2AX
also displayed an SLX4 stripe (data not shown).
Next, we tested the role of the SLX4 UBZ domains in
recruitment to sites of ICLs. Whereas SLX4 in normal human
fibroblasts formed stripes along tracks of PUVA-induced DNA
damage, SLX4 in fibroblasts from patients 457/1, 457/2 and 457/
3 did not (Fig. 1D). By contrast, immunoblotting of SLX4
immunoprecipitates showed that SLX4 was expressed at close-to-
normal levels in fibroblasts from FA patients 457/1–3, and that it
interacted normally with XPF–ERCC1, MUS81–EME1, SLX1
and C20ORF94 (supplementary material Fig. S1A,B). These data
suggest that at least one of the two SLX4 UBZ domains
recognizes a ubiquitylated protein at DNA damage sites, leading
to SLX4 recruitment.
Only one of the two SLX4 UBZ domains binds to ubiquitin
polymers
We next wished to explore the relative contribution of the
individual UBZ domains to SLX4 function, and we first
investigated ubiquitin binding. Maltose-binding protein (MBP)-
fused fragments of SLX4 containing both UBZ domains (UBZ-
1+UBZ-2) were immobilized on amylose–agarose beads. Mutant
proteins in which conserved cysteine residues in either the first or
Fig. 1. Recruitment of SLX4 to sites of localized DNA
damage induced by PUVA. (A) Diagram showing SLX4 domain
organization and associated nucleases. Siblings 457/1, 457/2
and 457/3 are FA patients with a deletion (outlined in black)
removing all of the second of the tandem SLX4 UBZ domains
and part of the first. BTB; Broad-complex, Tramtrack, Bric-a-brac
domain: SAP; SAF-A/B, Acinus and PIAS motif: HtH; helix-turn-
helix motif. (B) U2OS cells stably expressing GFP–SLX4 (upper
and lower panels) or GFP only (middle panels) were incubated
(or not) with trimethyl-psoralen (TMP; 20 mM, 60 min) and
subjected to subnuclear micro-irradiation using a 355-nm UV-A
laser. Cells were fixed and subjected to indirect
immunofluorescence analysis with antibodies against GFP or c-
H2AX. (C) As for B except the localization of endogenous SLX4
(endog.) in U2OS cells was examined. (D) Cells from FA patients
457/1, 457/2 and 457/3 or normal human fibroblasts were treated
as in B and endogenous SLX4 localization was analyzed by
using indirect immunofluorescence. Scale bars: 10 mm.
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the second UBZ domain were mutated to alanine –
C296A+C299A (UBZ-1*) and C336A+C339A (UBZ-2*),
respectively – were used as controls (Fig. 2A). MBP-tagged
SLX4 (UBZ-1+UBZ-2) showed robust binding to K63-linked
poly-ubiquitin chains but not to K48-linked polymers (Fig. 2B).
Mutating UBZ-1 abolished binding to K63-linked poly-
ubiquitin, whereas mutating UBZ-2 had no effect. Similar
data were obtained when the MBP tag was replaced with
GST (supplementary material Fig. S2A,B). Consistent with these
data, GST–UBZ-1 alone bound to K63-linked poly-ubiquitin, and
mutating the conserved cysteine residues abolished binding,
whereas GST–UBZ-2 alone did not bind to ubiquitin
(supplementary material Fig. S2A,B). A minimum of six
ubiquitin moieties was required for SLX4 (UBZ-1+UBZ-2)
fused to MBP (Fig. 2C) or GST (supplementary material Fig.
S2C) to bind to ubiquitin chains. Binding to mono-, di-, tri- or
tetra-ubiquitin was much weaker. These data show that SLX4
domain UBZ-1, but not UBZ-2, binds to poly-ubiquitin chains
with a preference for K63- over K48-linkages.
Recruitment of SLX4 to sites of DNA damage requires the
UBZ-1 domain, but not the UBZ-2 domain, FANCD2, RNF8,
RAD18 or BRCA1
We next tested the effect of UBZ mutations on the localization of
mouse SLX4 expressed in murine embryonic fibroblasts (MEFs)
from Slx42/2 mice (Castor et al., 2013). Slx42/2 MEFs were
infected with viruses containing wild-type SLX4 fused to GFP or
SLX4 bearing mutations in UBZ-1 (UBZ-1*) or UBZ-2 (UBZ-
2*). Both wild-type SLX4 and SLX4-UBZ-2* were recruited to
the sites of PUVA-induced ICLs, but the SLX4-UBZ-1* mutant
was not recruited to sites of DNA damage in any of the cells in
the population that had been micro-irradiated (Fig. 3A; data not
shown). Consistent with these data, UBZ-1 alone fused to both a
nuclear localization signal and GFP was capable of localizing at
Fig. 2. Testing the ability of the SLX4 UBZ domains
to bind to ubiquitin. (A) Diagram of the MBP-tagged
SLX4 fragments used in ubiquitin-binding assays.
Asterisks denote cysteine to alanine mutations at Cys
296 and Cys 299 in UBZ-1 (fragment 2) or Cys 336 and
Cys 339 in UBZ-2 (fragment 3). (B) The fragments
shown in A or MBP alone were immobilized on
amylose–agarose and incubated with K48-linked or
K63-linked poly-ubiquitin (pUb, 2–7) chains. Pulldowns
were subjected to SDS-PAGE and immunoblotted
(WB) with anti-ubiquitin antibodies. The bottom panel
shows a Ponceau staining of the membrane performed
prior to blotting. (C) Same as for B, except that mono-
ubiquitin or K63-linked poly-ubiquitin chains of the
indicated length were used with fragments 1–3.
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sites of PUVA-induced DNA damage, similar to wild-type SLX4,
although on average the intensity of the stripes was weaker than
that of stripes observed in cells containing wild-type SLX4
(supplementary material Fig. S3).
Mono-ubiquitylation of FANCD2 was reported to mediate
recruitment of chicken SLX4 to subnuclear foci in DT-40 cells
(Yamamoto et al., 2011). These data are at odds, however, with
the preference of the human SLX4 UBZ-1 domain for ubiquitin
polymers over mono-ubiquitin (Fig. 2C). In this light, we found
that SLX4 could form normal stripes along tracks of DNA
damage induced by PUVA treatment in FANCD22/2 (PD20)
human cells transfected with empty vector, in a manner that was
indistinguishable from PD20 cells expressing wild-type FANCD2
or a mutant K516R FANCD2 that could not be ubiquitylated
(Fig. 3B) (Garcia-Higuera et al., 2001).
Besides the FA core complex that ubiquitylates FANCD2
and FANCI, several other E3 ligases have been implicated in
ICL repair, including RAD18, which promotes FANCD2
ubiquitylation (Geng et al., 2010; Song et al., 2010), RNF8,
which promotes histone ubiquitylation and recruitment of
FAAP20 (Leung et al., 2012; Yan et al., 2012), and BRCA1,
although the E3 ligase activity of this protein might not be
required for DNA repair (Aressy and Greenberg, 2012). SLX4
recruitment to sites of PUVA-induced damage in (1) U2OS cells
stably expressing an RNF8 shRNA that prevented 53BP1
recruitment (supplementary material Fig. S3), (2) HCT-116
cells in which RAD18 was disrupted and (3) UWB1.289 cells,
which are null for BRCA1, was indistinguishable from that of the
relevant parental control cells; every cell with a stripe of c-H2AX
also had an SLX4 stripe of normal intensity (Fig. 3C). Taken
together, these data show that SLX4 is recruited to the sites of
DNA damage through its UBZ-1 domain, but the ubiquitylated
ligand in question is not FANCD2 in human cells and recruitment
does not require the E3 ligases that have already been implicated
in ICL repair.
SLX4 domain UBZ-1, but not UBZ-2, is required for ICL repair
We next tested the effect of UBZ domain mutations on the
sensitivity of cells to mitomycin C (MMC), as a readout of ICL
repair. Slx42/2 cells infected with empty pBABE-puro vector
Fig. 3. Relative contributions of the SLX4 UBZ domains to
DNA repair and recruitment to DNA damage sites.
(A) Slx42/2 MEFs were infected with retroviruses expressing
GFP-tagged mouse (m)SLX4 wild-type (WT), SLX4 UBZ-1* or
SLX4 UBZ-2*. Cells were incubated with trimethyl-psoralen
(TMP) and subjected to subnuclear micro-irradiation using a
355-nm UV-A laser. Cells were fixed and subjected to indirect
immunofluorescence analysis with antibodies against GFP or
c-H2AX. (B) PD20 cells lacking FANCD2 (upper panels), or
PD20 cells stably expressing FANCD2 (middle panels) or
FANCD2 K561R (lower panels), were subjected to laser
micro-irradiation as in A. Endogenous SLX4 and c-H2AX were
analyzed. (C) Same as for B, except that U2OS cells stably
expressing RNF8 shRNA plus parental cells, HCT-116 cells
lacking RAD18 plus parental cells or UWB1.289 cells lacking
BRCA1 were used. UWB1.289 cells expressing BRCA1 were
used as a control. For each population, ,300 cells were
counted, and representative images are shown. Scale bars:
10 mm.
SHORT REPORT Journal of Cell Science (2014) 127, 2811–2817 doi:10.1242/jcs.146167
2814
Jo
ur
na
l o
f C
el
l S
ci
en
ce
were much more sensitive to MMC than were wild-type cells
infected with the same virus (Fig. 4A). Furthermore, the MMC
hypersensitivity of Slx42/2 cells was rescued by untagged wild-
type mouse SLX4. The SLX4 UBZ-1* mutant was barely capable
of rescuing the MMC sensitivity of Slx42/2 cells, but the UBZ-2
mutant behaved like wild-type SLX4 (Fig. 4A). Consistent with
these data, Slx42/2 MEFs showed an increased incidence of
chromosome abnormalities (defined as breaks and radial
chromosomes), which was rescued by wild-type SLX4.
Mutating domain UBZ-1 completely prevented rescue, whereas
mutating UBZ-2 made no difference (Fig. 4B). Taken together,
these data show that SLX4 domain UBZ-1, but not UBZ-2, is
vital for the repair of ICLs.
Both SLX4 UBZ domains are required for the resolution of
Holliday junctions
SLX4 is required for around one third of the sister chromatid
exchanges (SCEs) induced by MMC in MEFs (Castor et al.,
2013), and we next tested the effect of UBZ domain mutations on
the occurrence of SCEs. As shown in Fig. 4C, MMC raises the
frequency of SCEs in wild-type MEFs by around 2.5 fold.
Compared with wild-type MEFs, Slx42/2 MEFs showed ,30%
fewer SCEs after treatment with MMC, but this defect was
rescued by wild-type SLX4 or SLX4-UBZ2*. No such rescue was
observed with the version of SLX4 bearing mutations in UBZ-1
(Fig. 4C).
SLX4 is required for the nucleolytic resolution of Holliday
junctions that escape dissolution by the BTR complex (Castor
et al., 2013; Wyatt et al., 2013). We next examined the
requirement of the SLX4 UBZ domains for resolution of
Holliday junctions in this context. Short hairpin (sh)RNA-
expressing retroviruses were used to deplete BLM from
Slx42/2 MEFs (Castor et al., 2013) (supplementary material
Fig. S4). Depletion of BLM from wild-type MEFs caused an
increase of ,2.5 fold in SCE frequency but this increase was
severely blunted in Slx42/2 MEFs (Fig. 4D). Wild-type SLX4
rescued this defect, but mutating either the first or the second
UBZ domain completely prevented rescue (Fig. 4D). These data
Fig. 4. Relative contributions of the SLX4 UBZ domains to
the resolution of Holliday junctions. (A) Clonogenic survival
analysis of Slx42/2 MEFs stably expressing untagged mouse
(m)SLX4, SLX4 UBZ-1* or SLX4 UBZ-2*, exposed to the
indicated doses of MMC. For each genotype, the viability of
untreated cells was defined as 100%. Wild-type MEFs and
Slx42/2 MEFs infected with empty virus (+vector) were used as
controls. Data represent the mean6s.e.m., n53.
(B) Metaphase spreads of MEFs treated with MMC (20 ng/ml)
were stained with DAPI and analyzed for the presence of radial
and broken chromosomes. Each cell line was either treated
with MMC or left untreated, and 50 metaphase spreads were
analyzed for each condition to determine the number of
abnormalities per metaphase. WT, wild-type. Data show the
mean6s.d. (C) Wild-type (Slx4+/+) MEFs, Slx42/2 MEFs and
Slx42/2 MEFs infected with retroviruses expressing wild-type
SLX4 (WT) or SLX4 bearing mutations in domains UBZ-1
(UBZ-1*) or UBZ-2 (UBZ-2*) were exposed to MMC (10 ng/ml)
and the frequency of SCEs was measured. (D) Same as for C,
expect that SCE frequencies in MEFs were measured after the
depletion of BLM. In C and D, 400 chromosomes in three
metaphase spreads (1200 in total) were analyzed. Data
represent the mean6s.e.m.
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suggest that both of the UBZ domains in SLX4 are required for
the resolution of Holliday junctions that escape dissolution.
In this study, we showed that the mutated form of SLX4
expressed in the cells of German siblings 457/1–3, which lacks all
of the second UBZ domain and part of the first, is not recruited
to sites of DNA damage. By analyzing the two domains
individually, we found that UBZ-1, but not UBZ-2, binds to
ubiquitin polymers, mediates recruitment of SLX4 to sites of
PUVA-induced DNA damage and is essential for both efficient
ICL repair and SCEs induced by ICLs in MEFs. Therefore, proper
targeting of SLX4, mediated by UBZ-1, appears to be essential
for ICL repair, and it is likely that failure to correctly target SLX4
explains the FA phenotype in patients 457/1-3.
What is the ubiquitylated ligand at sites of DNA damage that
recruits SLX4 through UBZ-1? The mono-ubiquitylated form of
FANCD2 was reported to be required for the formation of foci in
DT-40 chicken cells exposed to MMC (Yamamoto et al., 2011).
In the present study, we found that the recruitment of SLX4 to
sites of DNA damage induced in this manner occurs normally in
cells that lack FANCD2 and in cells lacking RAD18, which is
required for FANCD2 ubiquitylation (Geng et al., 2010; Song
et al., 2010). These data are consistent with our observation that
SLX4 only binds to poly-ubiquitin chains of at least six ubiquitin
moieties, whereas FANCD2 is mono-ubiquitylated, not poly-
ubiquitylated. We predict that there exists a poly-ubiquitylated
ligand that recruits SLX4 to sites of ICLs. It will be interesting to
identify this protein as well as the relevant E3 ligase involved,
which appears to be distinct from any of the E3 ligases previously
implicated in ICL repair.
Although SLX4 UBZ-2 is dispensable for ICL repair, it is
required, together with UBZ-1, for the resolution of Holliday
junctions that escape dissolution by the BTR complex. Recent
data from our lab suggests that the role of the SLX4 complex in
repairing ICLs is independent of Holliday junction cleavage and
probably reflects the cleavage of alternative branched DNA repair
intermediates (Castor et al., 2013). The observation in the present
study that SLX4 UBZ-2 is required for the resolution of Holliday
junctions that escape dissolution by BTR, but not for ICL repair,
is consistent with this idea. Even though UBZ-2 appears to have
all of the residues necessary for ubiquitin binding, it does not bind
to mono-ubiquitin or to K48- or K63-linked poly-ubiquitin chains
in vitro (Fig. 2). It is possible, however, that this domain binds to
atypical poly-ubiquitin chains such as K11, K27 or K33 linkages
or to a ubiquitin-like domain in the protein that recruits SLX4 to
sites of DNA damage. Finding the ligands for both of the SLX4
UBZ domains will be an interesting area of investigation.
MATERIALS AND METHODS
Cell lines
Mouse embryonic fibroblasts (MEFs) were grown in DMEM
supplemented with 10% fetal bovine serum (FBS) supplemented with
penicillin [1% (w/v)], streptomycin [1% (w/v)], sodium pyruvate and
non-essential amino acids at 37 C˚ in a humidified atmosphere under 5%
CO2. Normal human fibroblasts or fibroblasts from FA patients 457/1,
457/2 and 457/3 were immortalized with SV-40 and cultured in DMEM
medium supplemented with 10% FBS, 1% penicillin-streptomycin and
2 mM glutamine.
Laser irradiation and confocal microscopy
Cells seeded in 35-mm glass-bottomed dishes were incubated with
trimethyl-psoralen [TMP (25 mM); Sigma-Aldrich] for 60 min. A 355-
nm UV-A laser attached to a PALM microscope (Zeiss) was used to
irradiate a track along cell nuclei. The power of the laser (in terms of
percent intensity) was set to 20% to generate ICLs, and the areas were
struck at low speed. A 3620 pixel region internal to the nuclei of the cells
was targeted by using a Plan Fluor 406/1.25 NA oil objective. Cells were
then subjected to indirect immunofluorescence. Each experiment was
performed a minimum of three times, and a minimum of 100 cells were
PUVA treated per replicate.
Miscellaneous
Indirect immunofluorescence was carried out as described previously
(Wilson et al., 2013). Antibodies against mouse SLX4 and analysis of SCE
frequencies and chromosome abnormalities were described previously
(Castor et al., 2013).
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